Tailored QMS framework for innovative consumable reagent kit to comply with cell and gene therapy companies
Diarienummer | |
Koordinator | Countagen AB |
Bidrag från Vinnova | 200 000 kronor |
Projektets löptid | januari 2024 - augusti 2024 |
Status | Pågående |
Utlysning | Medtech4Health: kompetensförstärkning i småföretag |
Ansökningsomgång | Medtech4Health: Kompetensförstärkning i småföretag 2023 |
Syfte och mål
In this project, we aim to set up a customized quality management system (QMS) framework to ensure our quality and consistently deliver products that meet customers’ expectations while complying with relevant quality regulations. This strategic development in collaboration with PlantVision will be key to achieve our vision to become the gold standard for gene editing analysis by meeting industry standards for cell and gene therapy companies. The aim is to implement a QMS framework that follows and will support ISO 13485 which are relevant for the targeted market segment.
Förväntade effekter och resultat
This strategic development in collaboration with PlantVision will be key to achieve our vision to become the gold standard for gene editing analysis by meeting industry standards for cell and gene therapy companies. The aim is to implement a QMS framework that follows and will support ISO 13485 which are relevant for the targeted market segment.
Planerat upplägg och genomförande
QMS roadmap and strategy: 1. Needs analysis - a needs analysis is performed in form of a workshop. 2. Scope identification - the delivery manager of the project compiles the results of the workshop and makes an assessment of the most favorable strategy. 3. Project definition -a list of prioritized Standard operating procedures (SOP) are presented. 4. Issue review and approve documents - The SOPs are written. 5. Follow up - are done with company representatives. 6. Training - a specific training session are held for the whole company. 7. Hand over